Suchergebnisse - "Savaş GÜZEL"

PubPharm (16)

1

Serum Neudesin Levels in Obese Adolescents

in: JCRPE | 2022

von Aliye Çelikkol | Ciğdem Binay | Özge Ayçiçek | +1

2

Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients

in: International Journal of Hypertension | 2022

von Nergiz Bayrakci | Gülsüm Ozkan | Sonat Pinar Kara | +2

3

MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone

in: Renal Failure | 2021

von Sonat Pınar Kara | Gulsum Ozkan | Ahsen Yılmaz | +3

4

Assessment of salusin alpha and salusin beta levels in patients with newly diagnosed dipper and non-dipper hypertension

in: Clinical and Experimental Hypertension | 2021

von Seref Alpsoy | Burcin Dogan | Demet Ozkaramanli Gur | +4

5

Can Neutrophil/Lymphocyte Ratio be Used as a New Biomarker in the Evaluation of Disease Activity in Children with Bronchiolitis?

in: Namık Kemal Tıp Dergisi | 2019

von Eda ÇELİK GÜZEL | Çiğdem FİDAN | Savaş GÜZEL | +2

6

Causes of Elevated Levels of Serum CA 19.9 in Patients without Prior Diagnosis of Malignant Disease

in: Southern Clinics of Istanbul Eurasia | 2019

von Selcuk Şeber | Savaş Güzel | Ahsen Yılmaz | +2

7

Assessment of Iron Metabolism-Related Parameters in Obese Children

in: Avicenna Journal of Medical Biochemistry | 2019

von Mustafa Metin Donma | Zeynep Ersöz Güngör | Ahsen Yılmaz | +2

8

Relationship of serum salusin beta levels with coronary slow flow

in: Anatolian Journal of Cardiology | 2019

von Aydın Akyüz | Fatma Aydın | Şeref Alpsoy | +2

9

Soluble endothelial protein C is associated with blood pressure variability and salt consumption but not mean blood pressure in patients with newly diagnosed primary hypertension

in: Clinical and Experimental Hypertension | 2019

von Gülsüm Özkan | Sonat Pınar Kara | Çiğdem Fidan | +2

10

Tip 2 diyabetes mellituslu hastalarda C peptid ile mikroalbuminüri ilişkisi

in: Cukurova Medical Journal | 2018

von Banu BÖYÜK | Yıldız Okuturlar | Erdoğan Uludağ | +3